A phase 2 trial of dasatinib in patients with locally advanced or stage IV mucosal, acral, or vulvovaginal melanoma: A trial of the ECOG‐ACRIN Cancer Research Group (E2607)Kevin Kalinsky, John M. Kirkwood, Anthony J. Iafrarte et al.|Cancer|2017Cited by 125